Wespac Advisors So Cal, LLC Neurocrine Biosciences Inc Transaction History

Wespac Advisors So Cal, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$87.57 - $119.4 $215,860 - $294,321	-2,465 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$75.3 - $105.99 $185,614 - $261,265	2,465 New	2,465 $242,000
Q2 2018 Jul 13, 2018	SELL	$75.3 - $105.99 $50,074 - $70,483	-665 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$58.53 - $77.59 $38,922 - $51,597	665	665 $51,000

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.